MYD88 and cancer: MyD88 inhibitor, 4210, also slightly reduced TNFα levels in the culture medium treated with LPS (Supplementary Figure 2), suggesting that LPS stimulates TNFα production by the cancer cells through a MyD88-dependent pathway.